Serbia

 

CEE: Where and what to invest in

Under-penetrated and underserved markets in CEE are becoming too tempting to ignore for investors, claims Turkey-based regional expert Ufuk Eren, CEO of Volitan Consulting and advisor to EY. He spoke to Healthcare Europa at HBI 2018 in London and shared his thoughts about where he would recommend investing – and why.

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Klodian Allajbeu, CEO of American Hospital, Albania

American Hospital in Albania has five hospitals, a medical centre and a lab. Set up in 2006, it focussed initially on stemming the tide of private patients going abroad for treatment, not on the difficult task of trying to prize money from a public purse that was being spent almost exclusively on public hospitals. That may soon change, however. Healthcare Nova speaks to CEO Klodian Allajbeau to find out more.

HBI 2017: Central European brain drain – and how to stop it

One of the major problems faced by operators in Central and Eastern Europe (CEE) is brain drain - but how do you stop staff leaving for better paid jobs in the West, and if they do leave, how do you tempt them back? Healthcare Europa asked three leading CEE CEOs that very question at HBI 2017. This is their advice.

Interview: Marijan Bilic, Balkans director at Affidea

Netherlands-based pan-European diagnostics imaging group Affidea, which operates 220 diagnostics centres in 16 European countries, has just entered the Serbian market by opening a €4m neurology hospital in Belgrade. Affidea’s Balkans director Marijan Bilic explains why.

Affidea to launch diagnostics imaging network in Serbia

Pan-European diagnostics imaging provider Affidea has opened a €4m hospital in Belgrade last December and is planning to launch more facilities in other major cities in the next two years. We take a closer look at the company’s plans.

Interview: Attila Vegh, CEO, Penta Hospitals Group

By 2025 Penta Hospitals Group (PHG) owned by private equity house Penta Investments, plans to more than triple sales to over €1bn. But growth could be even faster, says its new CEO, Attila Vegh, a former boss of three large English NHS hospital trusts. The real ambition of the group, a merger of Svet Zdravia in Slovakia, the Polish chain EMC and Penta’s hospitals in Czech Republic, is even greater than the sales forecasts suggest. Much of the growth he says will come from working with the public sector. Vegh says that Penta wants to be “a disrupter, a company which introduces best practice and innovation,” thus persuading public payors to rethink their attitude to the private sector. So how do you do that in a region which is becoming increasingly statist and hostile to international capitalism?

Find Us